Given what I saw back then, I'm struggling to understand how there could possibly be "a library [..] of 6,111 molecules at various stages of investigation for human diseases" (a.k.a. "Drug Repurposing Hub") which hasn't already been partially or fully screened for interesting antibiotic activity.
Could it be there's more fame (and funding) in a project where you can publish a paper and get headlines about "ML" and "superbugs", than in actually testing a library of existing compounds to see if any of them kill E. coli?